These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37409398)

  • 21. In vivo evaluation of time-dependent antithrombotic effect of rivaroxaban-loaded poly(lactic-co-glycolic acid)/sodium lauryl sulfate or didodecyl dimethylammonium bromide nanoparticles in Wistar rats.
    de Souza Furtado P; Agnes Silva Camargo de Oliveira A; Santiago Rodrigues P; Rita Santiago de Paula Gonçalves A; Raphaella Autran Colaço A; Pinheiro da Costa S; Muniz da Paz M; Wetler Meireles Carreiros Assumpção P; Pereira Rangel L; Simon A; Almada do Carmo F; Mendes Cabral L; Cunha Sathler P
    Eur J Pharm Biopharm; 2023 Sep; 190():184-196. PubMed ID: 37517449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin.
    Hafezi Ghahestani Z; Alebooye Langroodi F; Mokhtarzadeh A; Ramezani M; Hashemi M
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):955-960. PubMed ID: 27327450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J; Zhang J; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel.
    Agrawal R; Shanavas A; Yadav S; Aslam M; Bahadur D; Srivastava R
    J Biomed Nanotechnol; 2012 Feb; 8(1):19-28. PubMed ID: 22515091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres.
    Rosa GD; Iommelli R; La Rotonda MI; Miro A; Quaglia F
    J Control Release; 2000 Nov; 69(2):283-95. PubMed ID: 11064135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrophobic ion pairing of a minocycline/Ca(2+)/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release.
    Holmkvist AD; Friberg A; Nilsson UJ; Schouenborg J
    Int J Pharm; 2016 Feb; 499(1-2):351-357. PubMed ID: 26773599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
    Mehta AK; Yadav KS; Sawant KK
    Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.
    Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE
    J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant poly(lactic-co-glycolic) acid nanoparticles made with α-tocopherol-ascorbic acid surfactant.
    Astete CE; Dolliver D; Whaley M; Khachatryan L; Sabliov CM
    ACS Nano; 2011 Dec; 5(12):9313-25. PubMed ID: 22017172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
    Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
    J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates.
    Park J; Mattessich T; Jay SM; Agawu A; Saltzman WM; Fahmy TM
    J Control Release; 2011 Nov; 156(1):109-15. PubMed ID: 21723893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of Drug Loaded PLGA Nanoparticles Prepared by Emulsification Solvent Evaporation Using Stirred Cell Ultrafiltration Technique.
    Paswan SK; Saini TR
    Pharm Res; 2017 Dec; 34(12):2779-2786. PubMed ID: 28924739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodegradable polymeric nanospheres formed by temperature-induced phase transition in a mixture of poly(lactide-co-glycolide) and poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer.
    Lee KE; Kim BK; Yuk SH
    Biomacromolecules; 2002; 3(5):1115-9. PubMed ID: 12217061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of surfactants on the properties of PLGA nanoparticles.
    Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
    J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles.
    Kennedy PJ; Perreira I; Ferreira D; Nestor M; Oliveira C; Granja PL; Sarmento B
    Eur J Pharm Biopharm; 2018 Jun; 127():366-370. PubMed ID: 29549023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLGA nanoparticles for peroral delivery: How important is pancreatic digestion and can we control it?
    Mante A; Heider M; Zlomke C; Mäder K
    Eur J Pharm Biopharm; 2016 Nov; 108():32-40. PubMed ID: 27553262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.